SlideShare una empresa de Scribd logo
1 de 19
KPSC DIABETES IN PREGNANCY
        PATHWAY
    Working Regional Guidelines
IMMEDIATE IMPACT FOR RIVERSIDE
• Centers will be INDIVIDUALLY graded
  regarding COMPLIANCE of the pathway.

• INDIVIDUAL MEDICAL CENTER PERFORMANCE
  and possibly some effect on BONUSES which
  will be determined by measuring the
  completion of TWO performance indicators
  MEASURED AS OF THIS JULY 1st 2012
MEDICAL CENTER PERFORMANCE INDICATORS
    TIED TO ACCOUNTABILITY/MONETARY
  INCENTIVE MEASURED AS OF JULY 1, 2012

COMPLETION OF TWO INDICATORS:
1.IN
2.OUT

Anticipate other indicators will be evaluated in
future
IN: HbA1c
• IN: All OB patients get a Hemoglobin A1c with
  INTAKE prenatal labs

  -they will be measuring the percentage of
  patients getting their HbA1c test on the FIRST
  prenatal visit (a measurement of our center's
  compliance with the Clinical Pathway)
OUT: FBS
2. OUT: All Patients with GDM COMPLETE a FBS test at the 6-
week post partum appointment:

A. Resolve GDM Diagnosis
B. Patient to be coded with HISTORY OF GDM
C. Patient will get a FBS test or a 2 hour GTT
-if normal: patient to be flagged for annual HbA1c test,
-if abnormal, refer patient to Primary care for diabetes
diagnosis confirmation and medical management.

As you know, A Fasting Blood Sugar (may also be called FPG,
fasting plasma glucose of 126 mg/dL or above is abnormal
and needs to be confirmed. The patient must be fasting of
everything except water for at least 8 hours prior to test)
KPSC DIABETES IN PREGNANCY
     CLINICAL PATHWAY
      COMPLETE PROGRAM
      REGIONAL GUIDELINES
Program Goals
• Improve and maintain member’s self care skills
  and provide treatment to avoid higher level of
  care
• Avoid Macrosomia, shoulder dystocia
• Avoid other pregnancy complications such as
  Cesarean delivery, NICU admission
• Intensive management to maximize proactive
  preventative therapy and medication monitoring
• Minimize the risk of maternal complications
  including worsening retinopathy, nephropathy,
  or hypertension in Pre-gestational Diabetes
  (PGDM)
DIABETES SCREENING & EDUCATION
    FOR ALL OBSTETRIC PATIENTS
 HgA1c with prenatal labs
 Risk assessment for GDM @ 1st visit
    HIGH RISK FOR GDM/NOT DM- Receive GCT/GTT ASAP
    LOW RISK FOR GDM- GCT/GTT @ 24-28 weeks
 Nutrition, Balanced Diet, Exercise Information
    Healthy Beginnings Newsletter AND/OR Prenatal Classes
 Proper weight gain during pregnancy
    Healthy Beginnings Newsletter AND/OR Prenatal Classes
 Risk Stratification of Diabetic Patients to Low,
  Medium, or High
    Based on history or documented laboratory criteria
DIABETES SCREENING AND
    EDUCATION FOR ALL OBSTETRIC
             PATIENTS
OB INTAKE/FIRST PRENATAL VISIT:
-ALL patients screened with hemoglobin A1c
with initial prenatal labs (first compliance measure)

-ALL patients are assessed for risk for GDM at
the first prenatal visit
DIABETES SCREENING STRATEGY
FIRST PRENATAL VISIT GDM RISK
      ASSESSMENT FOR DIABETES
             SCREENING
HIGH RISK of GDM: (ANY OF THESE)
-Personal history of GDM
-BMI ≥ 40
-Prior infant ≥ 4000 g (8 lbs 13 oz)
-Prior shoulder dystocia
-HgA1c 6.0 – 6.4 %
Possible Smart Phrase: GDM Risk
 Assessment. ANY Yes- Early GCT/GTT
GDM RISK ASSESSMENT:
1.Personal history of GDM: No/Yes
2.BMI ≥ 40: No/Yes “.bmi”
3.Prior infant ≥ 4000 g (8 lbs 13 oz): No/Yes
4. Prior shoulder dystocia: No/Yes
5.1st Trimester HgA1c 6-6.4%: No/Yes “.lasta1c” or
“Ordered and Pending”
ASSIGNED GDM SCREENING RISK:
Low- Patient for 24-28 week glucose testing unless
pending HgA1c results score HIGH
HIGH- Patient sent for GCT as soon as possible
FIRST PRENATAL VISIT
             ALL OB PATIENTS
• Nutrition, Balanced Diet, and Exercise
  Information
  – Healthy Beginnings Newsletter AND/OR Prenatal
    Classes
• Education regarding proper weight gain
  during pregnancy
  – Healthy Beginnings Newsletter AND/OR Prenatal
    Classes
Diabetic Patient Risk Stratification:
          Documented Criteria
LOW RISK: A1GDM
-Diagnosed as Gestational Diabetes BUT WITH first trimester
HgA1c < 6.5 %

MEDIUM RISK: A2GDM-good controlled
-Well-controlled A2GDM (on Insulin or Glyburide)

HIGH RISK: PGDM, A2GDM-poor control, 1st trimester A1c ≥ 6.5%
-POORLY Controlled A2GDM OR Pre-Gestational Diabetes Mellitus
(PGDM) (diagnosis at time of conception, or poorly controlled
A2GDM, or first trimester HgA1c ≥ 6.5%
Risk Group                                                             Intervention
                *Refer to Diabetes Care Team (includes class, nutritional counseling, dietician, certified Diabetes educator, social worker)
Low Risk
                *Issue Glucometer for blood sugar monitoring -FBS, 1 hour post prandial blood sugar after each meal
                *Blood sugar review at least every 2 weeks by OB Diabetes Care Team member
                *Consider Ultrasound to assess fetal growth between 36-38 weeks or when clinically indicated
  A1GDM with
                *If good glycemic control and no other complications, consider delivery NO LATER than 41 w 0 d
First Visit
                *If other complications such as poor compliance, history of HTN, history of stillbirth; consider delivery before 40 w 0 d
                • If EFW ≥ 4500 grams, consider c-section
                *At postpartum appointment -resolve GDM diagnosis and code history of GDM diagnosis in problem list
  A1c < 6.5 %
                *Order FBS or 2 hour GTT between 6-12 weeks postpartum (patient must complete)
Medium Risk *    All "Low Risk" Interventions
                *Refer to Diabetes Care Team (includes class, nutritional counseling, dietician, certified Diabetes educator, social worker)
      Well      *Blood sugar review at least every 1-2 weeks with adjustments of medication(s) by care provider
   controlled *  Non-stress testing twice weekly at 32 -34 weeks, or when medications starts after 32 weeks gestation
    A2GDM
 Requiring Rx • Consider delivery between 39-0/7 weeks and 40-0/7 weeks gestational age
                * All "Low Risk" and "Medium Risk" Interventions
                * Refer to Diabetes Care Team (includes class, nutritional counseling, dietician, certified Diabetes educator, social worker) and
                Perinatologist for Consultation of management if clinically indicated
                * Blood sugar review at least every 1-2 weeks with adjustments of medication(s) by care provider
                * Non-stress testing twice weekly at 32 -34 weeks (consider earlier testing if retinopathy, nephropathy, hypertension, poor
High Risk       glycemic control, IUGR)
                • If poor glucose control or other risk factors, consider amniocentesis for fetal lung maturity and delivery prior to 39 weeks.
    Poorly-     • If good glycemic control and no other complications, consider delivery at 39 w 0 d. Recommend delivery no later than 40 w
   controlled      0 d.
  A2GDM, or * Pre-Gestational Diabetes (PGDM):
PGDM, or           ***1st Trimester Labs: Serum Creatinine, TSH, ALT, AST, and random urine microalbumin (24 hour urine for total protein if
            1st microalbumin > 30)
Trimester A1c ***Eye photo (if not done 6-12 monhs prior to pregnancy); retinal eye exam (with dilation) if moderate or greater diabetic
    ≥ 6.5 %     retinopathy
                   *** EKG (if age 35 or older, or with vasculopathy, cardiac issues, or hypertension)
                   ***Targeted ultrasound (including careful assessment of fetal cardiac structures) at 18-22 weeks to rule out congenital
                anomalies
                   ***Repeat hemoglobin A1c in the third trimester (36 weeks)
                   ***Serial ultrasounds for fetal growth at 28 weeks gestation
PGDM Retinal Exam Algorithm
1.   GDM: No DR(Diabetic Retinopathy)screening
2.   PGDM: (Never had screening): Photo during pregnancy –No
     dilation*
3.   PDGM: (No DR, screen < 1yr): Photo during pregnancy
4.   PGDM: (No DR, HgA1c >7.5, screen > 6 mo ago): Photo during
     pregnancy –No dilation*
5.   PGDM: (Minimal DR with HgA1c 6.5 – 7.5, screened > 6mo ago):
     Photo during pregnancy: No dilation*, otherwise photo 1 year
6.   PGDM: (Minimal DR with HgA1c 6.5 – 7.5): Photo during
     pregnancy –No dilation*
7.   PGDM: (Moderate DR): EXAM DURING PREGNANCY WITH
     DILATION

*unless moderate or greater DR detected
OUT: Post-Partum Appointment
  ALL Patients diagnosed with Gestational
                  Diabetes
 Resolve GDM diagnosis and code with history of
  GDM diagnosis on patient problem list
 Fasting Blood Sugar (FBS) or 2 hour GTT is ordered
  and completed
 Patient is counseled regarding increased risk of GDM
  in future pregnancy
 Discuss options for birth control
 Patients less than 50 years old
Post Partum FBS Test by                                                       Interventions
OB/GYN
< 126 mg/dL                  •   No interventions from OB/GYN Needed
                             •   Patient with be “flagged” for Annual HbA1c test (results go to Diabetes Case Managers
                                 from Adult Primary Care)
≥ 126 mg/dL                  •   OB/GYN refer patient to adult primary care for diagnosis for Diabetes Mellitus and
                                 management
Annual HbA1c Screening* by                                                    Interventions
PCP
≤ 5.6%                       Continue annual HbA1c screening test
5.7 – 6.4 %                  •   Diabetes Case Managers will contact patient with results
                             •   Patients will be given resources to address exercise, weight loss, nutrition, and diabetes
                                 prevention (either Health Education Classes or Patient handouts)
                             •   Patient screened for reproductive plan: “Are you planning to become pregnant in the next
                                 year?”
                             o   No- assess for birth control and given referral for birth control if appropriate
                             o   YES- referral from preconception counseling (OB/GYN)
≥ 6.4 %                      • Diabetes Case Mangers will refer patient to adult primary care for diagnosis of
                               Diabetes Mellitus and management
                             • Patients will be given resources to address exercise, weight loss, nutrition, and
                               diabetes prevention (Heath education classes and/or Patient handouts)
                             • Patient screened for reproductive plan: “Are you planning to become pregnant
                               in the next year?”
                             o No- assess for birth control and given referral for birth control if appropriate
                             o YES- referral from preconception counseling (OB/GYN)
                             *1. A1c will be specifically labeled for post partum or pregnancy related- using batch order functions or
                             manual batch orders
                             2.Patients who miss their annual screening may receive a reminder outreach letter
                             3.Explore the possibility that results go into a pool
Possible Outcome Reports
1. Percentage of patients getting A1c on first prenatal visit (AS
   OF JULY 1 2012)
2. Postpartum Appointment Percentage Patients who:
   A.   Had GDM and COMPLETED FSB or 2 h GTT ordered (AS OF JULY 1
        2012)
   B.   Has PGDM got an A1C ordered
3. For all Mothers with GDM or PGDM, # of neonates ≥4500
   grams
4. For all Mothers with GDM/PGDM, the primary C-section rate
5. For all Mothers with GDM/PGDM, the number of NICU
   admissions at term (≥37.0 weeks)
6. For all Mothers with PGDM, the percentage of patients who
   have a 1st trimester A1c < 6.5% and the percentage of
   patients who have a A1c <6.5% in the third trimester (~36
   weeks)

Más contenido relacionado

La actualidad más candente

ueda2013 gestational diabetes-d.lobna
ueda2013 gestational diabetes-d.lobnaueda2013 gestational diabetes-d.lobna
ueda2013 gestational diabetes-d.lobnaueda2015
 
The Primary Care Guide for Pregnancy Diabetes
The Primary Care Guide for Pregnancy DiabetesThe Primary Care Guide for Pregnancy Diabetes
The Primary Care Guide for Pregnancy DiabetesHanifullah Khan
 
GESTATIONAL DIABETES MELLITUS
GESTATIONAL DIABETES MELLITUSGESTATIONAL DIABETES MELLITUS
GESTATIONAL DIABETES MELLITUSLipi Mondal
 
The Primary Care Physician's guide to management of Pregnancy Diabetes
The Primary Care Physician's guide to management of Pregnancy DiabetesThe Primary Care Physician's guide to management of Pregnancy Diabetes
The Primary Care Physician's guide to management of Pregnancy DiabetesHanifullah Khan
 
Gestational Diabetes Mellitus
Gestational Diabetes MellitusGestational Diabetes Mellitus
Gestational Diabetes Mellitusyashaswi pathak
 
Gestational diabetes mellitus
Gestational diabetes mellitusGestational diabetes mellitus
Gestational diabetes mellitusNabelle Rabbitson
 
Gdm diagnosis crieria and classification of hyperglycaemia first detected in...
Gdm  diagnosis crieria and classification of hyperglycaemia first detected in...Gdm  diagnosis crieria and classification of hyperglycaemia first detected in...
Gdm diagnosis crieria and classification of hyperglycaemia first detected in...Diabetes for all
 
Diabetes in pregnancy 2
Diabetes in pregnancy 2Diabetes in pregnancy 2
Diabetes in pregnancy 2obgymgmcri
 
Insulin in hyperglycemia in pregnancy
Insulin in hyperglycemia in pregnancyInsulin in hyperglycemia in pregnancy
Insulin in hyperglycemia in pregnancyNemencio Jr
 
FSHN450DiabetesCaseStudy
FSHN450DiabetesCaseStudyFSHN450DiabetesCaseStudy
FSHN450DiabetesCaseStudyAnna King
 
Management of diabetes during pregnancy
Management of diabetes during pregnancyManagement of diabetes during pregnancy
Management of diabetes during pregnancyAboubakr Elnashar
 
Vaccination in women from adolescence to menopause
Vaccination in women from adolescence to menopauseVaccination in women from adolescence to menopause
Vaccination in women from adolescence to menopauseDr Meenakshi Sharma
 
Diabetes Asia
Diabetes AsiaDiabetes Asia
Diabetes Asiadiab123
 

La actualidad más candente (19)

Diabetes in pregnancy
Diabetes in pregnancyDiabetes in pregnancy
Diabetes in pregnancy
 
ueda2013 gestational diabetes-d.lobna
ueda2013 gestational diabetes-d.lobnaueda2013 gestational diabetes-d.lobna
ueda2013 gestational diabetes-d.lobna
 
The Primary Care Guide for Pregnancy Diabetes
The Primary Care Guide for Pregnancy DiabetesThe Primary Care Guide for Pregnancy Diabetes
The Primary Care Guide for Pregnancy Diabetes
 
Gestational diabetes
Gestational diabetesGestational diabetes
Gestational diabetes
 
GESTATIONAL DIABETES MELLITUS
GESTATIONAL DIABETES MELLITUSGESTATIONAL DIABETES MELLITUS
GESTATIONAL DIABETES MELLITUS
 
Whats new in gdm
Whats new in gdmWhats new in gdm
Whats new in gdm
 
The Primary Care Physician's guide to management of Pregnancy Diabetes
The Primary Care Physician's guide to management of Pregnancy DiabetesThe Primary Care Physician's guide to management of Pregnancy Diabetes
The Primary Care Physician's guide to management of Pregnancy Diabetes
 
Gestational diabetes
Gestational diabetesGestational diabetes
Gestational diabetes
 
Dipsi guidelines
Dipsi guidelinesDipsi guidelines
Dipsi guidelines
 
Gestational Diabetes Mellitus
Gestational Diabetes MellitusGestational Diabetes Mellitus
Gestational Diabetes Mellitus
 
Gestational diabetes mellitus
Gestational diabetes mellitusGestational diabetes mellitus
Gestational diabetes mellitus
 
Gdm diagnosis crieria and classification of hyperglycaemia first detected in...
Gdm  diagnosis crieria and classification of hyperglycaemia first detected in...Gdm  diagnosis crieria and classification of hyperglycaemia first detected in...
Gdm diagnosis crieria and classification of hyperglycaemia first detected in...
 
Diabetes gestacional who 2013
Diabetes gestacional who 2013Diabetes gestacional who 2013
Diabetes gestacional who 2013
 
Diabetes in pregnancy 2
Diabetes in pregnancy 2Diabetes in pregnancy 2
Diabetes in pregnancy 2
 
Insulin in hyperglycemia in pregnancy
Insulin in hyperglycemia in pregnancyInsulin in hyperglycemia in pregnancy
Insulin in hyperglycemia in pregnancy
 
FSHN450DiabetesCaseStudy
FSHN450DiabetesCaseStudyFSHN450DiabetesCaseStudy
FSHN450DiabetesCaseStudy
 
Management of diabetes during pregnancy
Management of diabetes during pregnancyManagement of diabetes during pregnancy
Management of diabetes during pregnancy
 
Vaccination in women from adolescence to menopause
Vaccination in women from adolescence to menopauseVaccination in women from adolescence to menopause
Vaccination in women from adolescence to menopause
 
Diabetes Asia
Diabetes AsiaDiabetes Asia
Diabetes Asia
 

Destacado

Twins clinical management 2012
Twins clinical management 2012Twins clinical management 2012
Twins clinical management 2012Babak Jebelli
 
New Progesterone Guideline for Preterm labor and incidental shortened cervix
New Progesterone Guideline for Preterm labor and incidental shortened cervixNew Progesterone Guideline for Preterm labor and incidental shortened cervix
New Progesterone Guideline for Preterm labor and incidental shortened cervixBabak Jebelli
 
Ultrasonography of twin pregnancy SOGC GUIDELINE
Ultrasonography of twin pregnancy SOGC GUIDELINEUltrasonography of twin pregnancy SOGC GUIDELINE
Ultrasonography of twin pregnancy SOGC GUIDELINEAboubakr Elnashar
 
Twin to twin transfusion syndrome
Twin to twin transfusion syndromeTwin to twin transfusion syndrome
Twin to twin transfusion syndromeAmeer Salman
 
Late preterm delivery
Late preterm deliveryLate preterm delivery
Late preterm deliveryBabak Jebelli
 
Coccidioidomycosis in pregnancy
Coccidioidomycosis in pregnancyCoccidioidomycosis in pregnancy
Coccidioidomycosis in pregnancyBabak Jebelli
 
Heriditary spherocytosis
Heriditary spherocytosisHeriditary spherocytosis
Heriditary spherocytosisVijay Shankar
 
Cell injury: CELL ADAPTATIONS
Cell injury: CELL ADAPTATIONSCell injury: CELL ADAPTATIONS
Cell injury: CELL ADAPTATIONSVijay Shankar
 
Cell injury : Intracellular accumulations
Cell injury : Intracellular accumulationsCell injury : Intracellular accumulations
Cell injury : Intracellular accumulationsVijay Shankar
 
Aplastic and hypoproliferative anemias
Aplastic and hypoproliferative anemiasAplastic and hypoproliferative anemias
Aplastic and hypoproliferative anemiasVijay Shankar
 
RESPIRATORY SYSTEM: BRONCHIAL ASTHMA AND BRONCHIECTASIS
RESPIRATORY SYSTEM: BRONCHIAL ASTHMA AND BRONCHIECTASISRESPIRATORY SYSTEM: BRONCHIAL ASTHMA AND BRONCHIECTASIS
RESPIRATORY SYSTEM: BRONCHIAL ASTHMA AND BRONCHIECTASISVijay Shankar
 
RESPIRATORY SYSTEM: TUMORS OF LUNG & PLEURA
RESPIRATORY SYSTEM: TUMORS OF LUNG & PLEURARESPIRATORY SYSTEM: TUMORS OF LUNG & PLEURA
RESPIRATORY SYSTEM: TUMORS OF LUNG & PLEURAVijay Shankar
 
Cell injury: Pathologic calcification and Cell aging
Cell injury: Pathologic calcification and Cell agingCell injury: Pathologic calcification and Cell aging
Cell injury: Pathologic calcification and Cell agingVijay Shankar
 

Destacado (20)

Twins clinical management 2012
Twins clinical management 2012Twins clinical management 2012
Twins clinical management 2012
 
Economy
EconomyEconomy
Economy
 
New Progesterone Guideline for Preterm labor and incidental shortened cervix
New Progesterone Guideline for Preterm labor and incidental shortened cervixNew Progesterone Guideline for Preterm labor and incidental shortened cervix
New Progesterone Guideline for Preterm labor and incidental shortened cervix
 
Ultrasonography of twin pregnancy SOGC GUIDELINE
Ultrasonography of twin pregnancy SOGC GUIDELINEUltrasonography of twin pregnancy SOGC GUIDELINE
Ultrasonography of twin pregnancy SOGC GUIDELINE
 
Twin to twin transfusion syndrome
Twin to twin transfusion syndromeTwin to twin transfusion syndrome
Twin to twin transfusion syndrome
 
Hini2012 update
Hini2012 updateHini2012 update
Hini2012 update
 
Late preterm delivery
Late preterm deliveryLate preterm delivery
Late preterm delivery
 
Coccidioidomycosis in pregnancy
Coccidioidomycosis in pregnancyCoccidioidomycosis in pregnancy
Coccidioidomycosis in pregnancy
 
Cnmnpcpsp
CnmnpcpspCnmnpcpsp
Cnmnpcpsp
 
A Case of Pure Red Cell Aplasia
A Case of Pure Red Cell AplasiaA Case of Pure Red Cell Aplasia
A Case of Pure Red Cell Aplasia
 
Heriditary spherocytosis
Heriditary spherocytosisHeriditary spherocytosis
Heriditary spherocytosis
 
Cell injury: CELL ADAPTATIONS
Cell injury: CELL ADAPTATIONSCell injury: CELL ADAPTATIONS
Cell injury: CELL ADAPTATIONS
 
Cell injury : Intracellular accumulations
Cell injury : Intracellular accumulationsCell injury : Intracellular accumulations
Cell injury : Intracellular accumulations
 
Aplastic and hypoproliferative anemias
Aplastic and hypoproliferative anemiasAplastic and hypoproliferative anemias
Aplastic and hypoproliferative anemias
 
RESPIRATORY SYSTEM: BRONCHIAL ASTHMA AND BRONCHIECTASIS
RESPIRATORY SYSTEM: BRONCHIAL ASTHMA AND BRONCHIECTASISRESPIRATORY SYSTEM: BRONCHIAL ASTHMA AND BRONCHIECTASIS
RESPIRATORY SYSTEM: BRONCHIAL ASTHMA AND BRONCHIECTASIS
 
RESPIRATORY SYSTEM: TUMORS OF LUNG & PLEURA
RESPIRATORY SYSTEM: TUMORS OF LUNG & PLEURARESPIRATORY SYSTEM: TUMORS OF LUNG & PLEURA
RESPIRATORY SYSTEM: TUMORS OF LUNG & PLEURA
 
Pph share drive
Pph share drive Pph share drive
Pph share drive
 
Acute leukemias
Acute leukemiasAcute leukemias
Acute leukemias
 
Cell injury: Pathologic calcification and Cell aging
Cell injury: Pathologic calcification and Cell agingCell injury: Pathologic calcification and Cell aging
Cell injury: Pathologic calcification and Cell aging
 
Cd004661 abstract
Cd004661 abstractCd004661 abstract
Cd004661 abstract
 

Similar a Kpsc diabetes in pregnancy pathway 8.6.2012

pg case presentation , obstetrics
 pg case presentation , obstetrics pg case presentation , obstetrics
pg case presentation , obstetricsGitanjali Kumari
 
Gestational Diabetes mellitus (GDM) for Students
Gestational Diabetes mellitus (GDM) for StudentsGestational Diabetes mellitus (GDM) for Students
Gestational Diabetes mellitus (GDM) for StudentsUsama Ragab
 
Revised PPT GDM- clinical and nutritional perspective.pptx
Revised PPT GDM- clinical and nutritional perspective.pptxRevised PPT GDM- clinical and nutritional perspective.pptx
Revised PPT GDM- clinical and nutritional perspective.pptxVidushRatan1
 
gestational Diabetes Mellitus
gestational Diabetes Mellitusgestational Diabetes Mellitus
gestational Diabetes MellitusSujoy Dasgupta
 
Ada 2015 summary pdf
Ada 2015 summary pdfAda 2015 summary pdf
Ada 2015 summary pdfoth khairy
 
Ada 2015 summary pdf
Ada 2015 summary pdfAda 2015 summary pdf
Ada 2015 summary pdfRika S
 
Gestational Diabetes & Gestational HTN
Gestational Diabetes & Gestational HTN Gestational Diabetes & Gestational HTN
Gestational Diabetes & Gestational HTN taherzy1406
 
Executive summary-standards of Medical care in Diabetes 2014
Executive summary-standards of Medical care in Diabetes 2014Executive summary-standards of Medical care in Diabetes 2014
Executive summary-standards of Medical care in Diabetes 2014Suneth Weerarathna
 
2015-08-06 PSEDM 16th Diabetes and General Endocrinology Course in Bacolod - ...
2015-08-06 PSEDM 16th Diabetes and General Endocrinology Course in Bacolod - ...2015-08-06 PSEDM 16th Diabetes and General Endocrinology Course in Bacolod - ...
2015-08-06 PSEDM 16th Diabetes and General Endocrinology Course in Bacolod - ...Jeremy F. Robles MD, FPCP, FPSEM
 
NCD Training Module 4.8 Hyperglycaemia in Pregnancy.ppt
NCD Training Module 4.8 Hyperglycaemia in Pregnancy.pptNCD Training Module 4.8 Hyperglycaemia in Pregnancy.ppt
NCD Training Module 4.8 Hyperglycaemia in Pregnancy.pptCHRISTOPHERMKONO2
 
Gestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptxGestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptxsusanta12
 
GESTATIONAL DIABETES MELLITUS
GESTATIONAL DIABETES MELLITUSGESTATIONAL DIABETES MELLITUS
GESTATIONAL DIABETES MELLITUSSangeethaVijian
 
Diabetes in pregnancy : medical management
Diabetes in pregnancy : medical managementDiabetes in pregnancy : medical management
Diabetes in pregnancy : medical managementRadwa Rasheedy
 
Diabetes in Pregnancy.pptx
Diabetes in Pregnancy.pptxDiabetes in Pregnancy.pptx
Diabetes in Pregnancy.pptxssuser0c24c8
 
monitoring During Pregnancy by diabetesasia.org
monitoring During Pregnancy by diabetesasia.orgmonitoring During Pregnancy by diabetesasia.org
monitoring During Pregnancy by diabetesasia.orgDiabetes Asia
 

Similar a Kpsc diabetes in pregnancy pathway 8.6.2012 (20)

pg case presentation , obstetrics
 pg case presentation , obstetrics pg case presentation , obstetrics
pg case presentation , obstetrics
 
Gestational Diabetes mellitus (GDM) for Students
Gestational Diabetes mellitus (GDM) for StudentsGestational Diabetes mellitus (GDM) for Students
Gestational Diabetes mellitus (GDM) for Students
 
Revised PPT GDM- clinical and nutritional perspective.pptx
Revised PPT GDM- clinical and nutritional perspective.pptxRevised PPT GDM- clinical and nutritional perspective.pptx
Revised PPT GDM- clinical and nutritional perspective.pptx
 
gestational Diabetes Mellitus
gestational Diabetes Mellitusgestational Diabetes Mellitus
gestational Diabetes Mellitus
 
Diabetes Asia
Diabetes AsiaDiabetes Asia
Diabetes Asia
 
Ada 2015 summary pdf
Ada 2015 summary pdfAda 2015 summary pdf
Ada 2015 summary pdf
 
Ada 2015 summary pdf
Ada 2015 summary pdfAda 2015 summary pdf
Ada 2015 summary pdf
 
Gestational Diabetes & Gestational HTN
Gestational Diabetes & Gestational HTN Gestational Diabetes & Gestational HTN
Gestational Diabetes & Gestational HTN
 
Executive summary-standards of Medical care in Diabetes 2014
Executive summary-standards of Medical care in Diabetes 2014Executive summary-standards of Medical care in Diabetes 2014
Executive summary-standards of Medical care in Diabetes 2014
 
GDM
GDMGDM
GDM
 
Gdm Satellite Congress
Gdm Satellite CongressGdm Satellite Congress
Gdm Satellite Congress
 
2015-08-06 PSEDM 16th Diabetes and General Endocrinology Course in Bacolod - ...
2015-08-06 PSEDM 16th Diabetes and General Endocrinology Course in Bacolod - ...2015-08-06 PSEDM 16th Diabetes and General Endocrinology Course in Bacolod - ...
2015-08-06 PSEDM 16th Diabetes and General Endocrinology Course in Bacolod - ...
 
NCD Training Module 4.8 Hyperglycaemia in Pregnancy.ppt
NCD Training Module 4.8 Hyperglycaemia in Pregnancy.pptNCD Training Module 4.8 Hyperglycaemia in Pregnancy.ppt
NCD Training Module 4.8 Hyperglycaemia in Pregnancy.ppt
 
Gestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptxGestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptx
 
GESTATIONAL DIABETES MELLITUS
GESTATIONAL DIABETES MELLITUSGESTATIONAL DIABETES MELLITUS
GESTATIONAL DIABETES MELLITUS
 
Diabetes in pregnancy : medical management
Diabetes in pregnancy : medical managementDiabetes in pregnancy : medical management
Diabetes in pregnancy : medical management
 
Diabetes
DiabetesDiabetes
Diabetes
 
Diabetes in Pregnancy.pptx
Diabetes in Pregnancy.pptxDiabetes in Pregnancy.pptx
Diabetes in Pregnancy.pptx
 
gdm (1).pptx
gdm (1).pptxgdm (1).pptx
gdm (1).pptx
 
monitoring During Pregnancy by diabetesasia.org
monitoring During Pregnancy by diabetesasia.orgmonitoring During Pregnancy by diabetesasia.org
monitoring During Pregnancy by diabetesasia.org
 

Más de Babak Jebelli

Medication 53333-phpapp02
Medication 53333-phpapp02Medication 53333-phpapp02
Medication 53333-phpapp02Babak Jebelli
 
Hcahps score trends in the past 4 years
Hcahps score trends in the past 4 yearsHcahps score trends in the past 4 years
Hcahps score trends in the past 4 yearsBabak Jebelli
 
Von willebrands disease
Von willebrands diseaseVon willebrands disease
Von willebrands diseaseBabak Jebelli
 
Insulin resistance and pcos
Insulin resistance and pcosInsulin resistance and pcos
Insulin resistance and pcosBabak Jebelli
 
Fht interpretation & management
Fht interpretation & managementFht interpretation & management
Fht interpretation & managementBabak Jebelli
 
Asymptomatic short cervix and vaginanal, progesterone
Asymptomatic short cervix and vaginanal, progesteroneAsymptomatic short cervix and vaginanal, progesterone
Asymptomatic short cervix and vaginanal, progesteroneBabak Jebelli
 
Prevention of pertussis
Prevention of pertussisPrevention of pertussis
Prevention of pertussisBabak Jebelli
 
Von willebrands disease
Von willebrands diseaseVon willebrands disease
Von willebrands diseaseBabak Jebelli
 
Toxic shock syndrome
Toxic shock syndromeToxic shock syndrome
Toxic shock syndromeBabak Jebelli
 

Más de Babak Jebelli (20)

Medication 53333-phpapp02
Medication 53333-phpapp02Medication 53333-phpapp02
Medication 53333-phpapp02
 
Hcahps score trends in the past 4 years
Hcahps score trends in the past 4 yearsHcahps score trends in the past 4 years
Hcahps score trends in the past 4 years
 
Von willebrands disease
Von willebrands diseaseVon willebrands disease
Von willebrands disease
 
Insulin resistance and pcos
Insulin resistance and pcosInsulin resistance and pcos
Insulin resistance and pcos
 
Induction summary
Induction summaryInduction summary
Induction summary
 
Hyperemesis6 12
Hyperemesis6 12Hyperemesis6 12
Hyperemesis6 12
 
Gbs 2010
Gbs 2010Gbs 2010
Gbs 2010
 
Foley bulb
Foley bulbFoley bulb
Foley bulb
 
Fht interpretation & management
Fht interpretation & managementFht interpretation & management
Fht interpretation & management
 
Asymptomatic short cervix and vaginanal, progesterone
Asymptomatic short cervix and vaginanal, progesteroneAsymptomatic short cervix and vaginanal, progesterone
Asymptomatic short cervix and vaginanal, progesterone
 
Prevention of pertussis
Prevention of pertussisPrevention of pertussis
Prevention of pertussis
 
Magnesium sulfate
Magnesium sulfateMagnesium sulfate
Magnesium sulfate
 
Labor down
Labor downLabor down
Labor down
 
Vte prophylaxis
Vte prophylaxisVte prophylaxis
Vte prophylaxis
 
Von willebrands disease
Von willebrands diseaseVon willebrands disease
Von willebrands disease
 
Vbac tables
Vbac tablesVbac tables
Vbac tables
 
Vbac2010a
Vbac2010aVbac2010a
Vbac2010a
 
Uterine inversion
Uterine inversionUterine inversion
Uterine inversion
 
Toxic shock syndrome
Toxic shock syndromeToxic shock syndrome
Toxic shock syndrome
 
Tolac calculator
Tolac calculatorTolac calculator
Tolac calculator
 

Kpsc diabetes in pregnancy pathway 8.6.2012

  • 1. KPSC DIABETES IN PREGNANCY PATHWAY Working Regional Guidelines
  • 2. IMMEDIATE IMPACT FOR RIVERSIDE • Centers will be INDIVIDUALLY graded regarding COMPLIANCE of the pathway. • INDIVIDUAL MEDICAL CENTER PERFORMANCE and possibly some effect on BONUSES which will be determined by measuring the completion of TWO performance indicators MEASURED AS OF THIS JULY 1st 2012
  • 3. MEDICAL CENTER PERFORMANCE INDICATORS TIED TO ACCOUNTABILITY/MONETARY INCENTIVE MEASURED AS OF JULY 1, 2012 COMPLETION OF TWO INDICATORS: 1.IN 2.OUT Anticipate other indicators will be evaluated in future
  • 4. IN: HbA1c • IN: All OB patients get a Hemoglobin A1c with INTAKE prenatal labs -they will be measuring the percentage of patients getting their HbA1c test on the FIRST prenatal visit (a measurement of our center's compliance with the Clinical Pathway)
  • 5. OUT: FBS 2. OUT: All Patients with GDM COMPLETE a FBS test at the 6- week post partum appointment: A. Resolve GDM Diagnosis B. Patient to be coded with HISTORY OF GDM C. Patient will get a FBS test or a 2 hour GTT -if normal: patient to be flagged for annual HbA1c test, -if abnormal, refer patient to Primary care for diabetes diagnosis confirmation and medical management. As you know, A Fasting Blood Sugar (may also be called FPG, fasting plasma glucose of 126 mg/dL or above is abnormal and needs to be confirmed. The patient must be fasting of everything except water for at least 8 hours prior to test)
  • 6. KPSC DIABETES IN PREGNANCY CLINICAL PATHWAY COMPLETE PROGRAM REGIONAL GUIDELINES
  • 7. Program Goals • Improve and maintain member’s self care skills and provide treatment to avoid higher level of care • Avoid Macrosomia, shoulder dystocia • Avoid other pregnancy complications such as Cesarean delivery, NICU admission • Intensive management to maximize proactive preventative therapy and medication monitoring • Minimize the risk of maternal complications including worsening retinopathy, nephropathy, or hypertension in Pre-gestational Diabetes (PGDM)
  • 8. DIABETES SCREENING & EDUCATION FOR ALL OBSTETRIC PATIENTS  HgA1c with prenatal labs  Risk assessment for GDM @ 1st visit  HIGH RISK FOR GDM/NOT DM- Receive GCT/GTT ASAP  LOW RISK FOR GDM- GCT/GTT @ 24-28 weeks  Nutrition, Balanced Diet, Exercise Information  Healthy Beginnings Newsletter AND/OR Prenatal Classes  Proper weight gain during pregnancy  Healthy Beginnings Newsletter AND/OR Prenatal Classes  Risk Stratification of Diabetic Patients to Low, Medium, or High  Based on history or documented laboratory criteria
  • 9. DIABETES SCREENING AND EDUCATION FOR ALL OBSTETRIC PATIENTS OB INTAKE/FIRST PRENATAL VISIT: -ALL patients screened with hemoglobin A1c with initial prenatal labs (first compliance measure) -ALL patients are assessed for risk for GDM at the first prenatal visit
  • 11. FIRST PRENATAL VISIT GDM RISK ASSESSMENT FOR DIABETES SCREENING HIGH RISK of GDM: (ANY OF THESE) -Personal history of GDM -BMI ≥ 40 -Prior infant ≥ 4000 g (8 lbs 13 oz) -Prior shoulder dystocia -HgA1c 6.0 – 6.4 %
  • 12. Possible Smart Phrase: GDM Risk Assessment. ANY Yes- Early GCT/GTT GDM RISK ASSESSMENT: 1.Personal history of GDM: No/Yes 2.BMI ≥ 40: No/Yes “.bmi” 3.Prior infant ≥ 4000 g (8 lbs 13 oz): No/Yes 4. Prior shoulder dystocia: No/Yes 5.1st Trimester HgA1c 6-6.4%: No/Yes “.lasta1c” or “Ordered and Pending” ASSIGNED GDM SCREENING RISK: Low- Patient for 24-28 week glucose testing unless pending HgA1c results score HIGH HIGH- Patient sent for GCT as soon as possible
  • 13. FIRST PRENATAL VISIT ALL OB PATIENTS • Nutrition, Balanced Diet, and Exercise Information – Healthy Beginnings Newsletter AND/OR Prenatal Classes • Education regarding proper weight gain during pregnancy – Healthy Beginnings Newsletter AND/OR Prenatal Classes
  • 14. Diabetic Patient Risk Stratification: Documented Criteria LOW RISK: A1GDM -Diagnosed as Gestational Diabetes BUT WITH first trimester HgA1c < 6.5 % MEDIUM RISK: A2GDM-good controlled -Well-controlled A2GDM (on Insulin or Glyburide) HIGH RISK: PGDM, A2GDM-poor control, 1st trimester A1c ≥ 6.5% -POORLY Controlled A2GDM OR Pre-Gestational Diabetes Mellitus (PGDM) (diagnosis at time of conception, or poorly controlled A2GDM, or first trimester HgA1c ≥ 6.5%
  • 15. Risk Group Intervention *Refer to Diabetes Care Team (includes class, nutritional counseling, dietician, certified Diabetes educator, social worker) Low Risk *Issue Glucometer for blood sugar monitoring -FBS, 1 hour post prandial blood sugar after each meal *Blood sugar review at least every 2 weeks by OB Diabetes Care Team member *Consider Ultrasound to assess fetal growth between 36-38 weeks or when clinically indicated A1GDM with *If good glycemic control and no other complications, consider delivery NO LATER than 41 w 0 d First Visit *If other complications such as poor compliance, history of HTN, history of stillbirth; consider delivery before 40 w 0 d • If EFW ≥ 4500 grams, consider c-section *At postpartum appointment -resolve GDM diagnosis and code history of GDM diagnosis in problem list A1c < 6.5 % *Order FBS or 2 hour GTT between 6-12 weeks postpartum (patient must complete) Medium Risk * All "Low Risk" Interventions *Refer to Diabetes Care Team (includes class, nutritional counseling, dietician, certified Diabetes educator, social worker) Well *Blood sugar review at least every 1-2 weeks with adjustments of medication(s) by care provider controlled * Non-stress testing twice weekly at 32 -34 weeks, or when medications starts after 32 weeks gestation A2GDM Requiring Rx • Consider delivery between 39-0/7 weeks and 40-0/7 weeks gestational age * All "Low Risk" and "Medium Risk" Interventions * Refer to Diabetes Care Team (includes class, nutritional counseling, dietician, certified Diabetes educator, social worker) and Perinatologist for Consultation of management if clinically indicated * Blood sugar review at least every 1-2 weeks with adjustments of medication(s) by care provider * Non-stress testing twice weekly at 32 -34 weeks (consider earlier testing if retinopathy, nephropathy, hypertension, poor High Risk glycemic control, IUGR) • If poor glucose control or other risk factors, consider amniocentesis for fetal lung maturity and delivery prior to 39 weeks. Poorly- • If good glycemic control and no other complications, consider delivery at 39 w 0 d. Recommend delivery no later than 40 w controlled 0 d. A2GDM, or * Pre-Gestational Diabetes (PGDM): PGDM, or ***1st Trimester Labs: Serum Creatinine, TSH, ALT, AST, and random urine microalbumin (24 hour urine for total protein if 1st microalbumin > 30) Trimester A1c ***Eye photo (if not done 6-12 monhs prior to pregnancy); retinal eye exam (with dilation) if moderate or greater diabetic ≥ 6.5 % retinopathy *** EKG (if age 35 or older, or with vasculopathy, cardiac issues, or hypertension) ***Targeted ultrasound (including careful assessment of fetal cardiac structures) at 18-22 weeks to rule out congenital anomalies ***Repeat hemoglobin A1c in the third trimester (36 weeks) ***Serial ultrasounds for fetal growth at 28 weeks gestation
  • 16. PGDM Retinal Exam Algorithm 1. GDM: No DR(Diabetic Retinopathy)screening 2. PGDM: (Never had screening): Photo during pregnancy –No dilation* 3. PDGM: (No DR, screen < 1yr): Photo during pregnancy 4. PGDM: (No DR, HgA1c >7.5, screen > 6 mo ago): Photo during pregnancy –No dilation* 5. PGDM: (Minimal DR with HgA1c 6.5 – 7.5, screened > 6mo ago): Photo during pregnancy: No dilation*, otherwise photo 1 year 6. PGDM: (Minimal DR with HgA1c 6.5 – 7.5): Photo during pregnancy –No dilation* 7. PGDM: (Moderate DR): EXAM DURING PREGNANCY WITH DILATION *unless moderate or greater DR detected
  • 17. OUT: Post-Partum Appointment ALL Patients diagnosed with Gestational Diabetes  Resolve GDM diagnosis and code with history of GDM diagnosis on patient problem list  Fasting Blood Sugar (FBS) or 2 hour GTT is ordered and completed  Patient is counseled regarding increased risk of GDM in future pregnancy  Discuss options for birth control  Patients less than 50 years old
  • 18. Post Partum FBS Test by Interventions OB/GYN < 126 mg/dL • No interventions from OB/GYN Needed • Patient with be “flagged” for Annual HbA1c test (results go to Diabetes Case Managers from Adult Primary Care) ≥ 126 mg/dL • OB/GYN refer patient to adult primary care for diagnosis for Diabetes Mellitus and management Annual HbA1c Screening* by Interventions PCP ≤ 5.6% Continue annual HbA1c screening test 5.7 – 6.4 % • Diabetes Case Managers will contact patient with results • Patients will be given resources to address exercise, weight loss, nutrition, and diabetes prevention (either Health Education Classes or Patient handouts) • Patient screened for reproductive plan: “Are you planning to become pregnant in the next year?” o No- assess for birth control and given referral for birth control if appropriate o YES- referral from preconception counseling (OB/GYN) ≥ 6.4 % • Diabetes Case Mangers will refer patient to adult primary care for diagnosis of Diabetes Mellitus and management • Patients will be given resources to address exercise, weight loss, nutrition, and diabetes prevention (Heath education classes and/or Patient handouts) • Patient screened for reproductive plan: “Are you planning to become pregnant in the next year?” o No- assess for birth control and given referral for birth control if appropriate o YES- referral from preconception counseling (OB/GYN) *1. A1c will be specifically labeled for post partum or pregnancy related- using batch order functions or manual batch orders 2.Patients who miss their annual screening may receive a reminder outreach letter 3.Explore the possibility that results go into a pool
  • 19. Possible Outcome Reports 1. Percentage of patients getting A1c on first prenatal visit (AS OF JULY 1 2012) 2. Postpartum Appointment Percentage Patients who: A. Had GDM and COMPLETED FSB or 2 h GTT ordered (AS OF JULY 1 2012) B. Has PGDM got an A1C ordered 3. For all Mothers with GDM or PGDM, # of neonates ≥4500 grams 4. For all Mothers with GDM/PGDM, the primary C-section rate 5. For all Mothers with GDM/PGDM, the number of NICU admissions at term (≥37.0 weeks) 6. For all Mothers with PGDM, the percentage of patients who have a 1st trimester A1c < 6.5% and the percentage of patients who have a A1c <6.5% in the third trimester (~36 weeks)

Notas del editor

  1. F.
  2. HIGH RISK FOR GDM: Personal h/o GDM, Previous Infant &gt;4000 g, BMI &gt;/= 40, Prior shoulder dystocia, Ist trimester HbA1c 6-6.4%